ArticleJournal of medical virology2025

PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis.

Lisa Beatrice Caruso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.